Zai Lab Limited
ZLAB
$18.37
-$0.50-2.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.91% | 5.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.91% | 5.56% | |||
| Cost of Revenue | 30.75% | 1.04% | |||
| Gross Profit | -82.93% | 31.85% | |||
| SG&A Expenses | 4.18% | -1.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.46% | 0.03% | |||
| Operating Income | -42.16% | 11.06% | |||
| Income Before Tax | -48.31% | 11.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -40.17% | 11.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -40.17% | 11.70% | |||
| EBIT | -42.16% | 11.06% | |||
| EBITDA | -45.79% | 12.20% | |||
| EPS Basic | -39.69% | 12.52% | |||
| Normalized Basic EPS | -47.75% | 12.48% | |||
| EPS Diluted | -39.69% | 12.52% | |||
| Normalized Diluted EPS | -47.75% | 12.48% | |||
| Average Basic Shares Outstanding | 0.36% | 0.93% | |||
| Average Diluted Shares Outstanding | 0.36% | 0.93% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||